Cofinimmo SA

BRSE:COF Stock Report

Market Cap: CHF 2.9b

Cofinimmo Valuation

Is COF undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of COF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: COF (CHF73.72) is trading above our estimate of future cash flow value (CHF31.86)

Significantly Below Future Cash Flow Value: COF is trading above our estimate of future cash flow value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for COF?

Key metric: As COF is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for COF. This is calculated by dividing COF's market cap by their current earnings.
What is COF's PE Ratio?
PE Ratio15.3x
Earnings€202.71m
Market Cap€3.11b

Price to Earnings Ratio vs Peers

How does COF's PE Ratio compare to its peers?

The above table shows the PE ratio for COF vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average22.4x
NHI National Health Investors
23.5x8.32%US$3.4b
PHP Primary Health Properties
20.1x16.41%UK£2.4b
SBRA Sabra Health Care REIT
30x13.53%US$4.7b
C2PU Parkway Life Real Estate Investment Trust
16x-11.66%S$2.6b
COF Cofinimmo
15.3x7.63%CHF 3.1b

Price-To-Earnings vs Peers: COF is good value based on its Price-To-Earnings Ratio (15.3x) compared to the peer average (22.4x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does COF's PE Ratio compare vs other companies in the Global Health Care REITs Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
COF 15.3xIndustry Avg. 19.4xNo. of Companies5PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: COF is good value based on its Price-To-Earnings Ratio (15.3x) compared to the Global Health Care REITs industry average (19.6x).

Price to Earnings Ratio vs Fair Ratio

What is COF's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

COF PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio15.3x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate COF's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst COF forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
CHF 79.92
0%
9.96%CHF 95.11CHF 70.42n/a10
Jun ’27n/a
CHF 79.92
0%
9.96%CHF 95.11CHF 70.42n/a10
May ’27n/a
CHF 79.18
0%
10.85%CHF 95.56CHF 70.06n/a10
Apr ’27n/a
CHF 78.90
0%
10.85%CHF 95.22CHF 69.81n/a10
Mar ’27n/a
CHF 78.72
0%
10.85%CHF 95.01CHF 69.66n/a10
Feb ’27n/a
CHF 76.75
0%
9.78%CHF 95.34CHF 69.90n/a10
Jan ’27n/a
CHF 75.76
0%
6.00%CHF 86.01CHF 70.96n/a9
Dec ’26n/a
CHF 76.25
0%
5.90%CHF 86.10CHF 71.03n/a10
Nov ’26n/a
CHF 75.07
0%
4.17%CHF 79.71CHF 70.74n/a10
Oct ’26n/a
CHF 75.09
0%
4.36%CHF 80.35CHF 71.31n/a10
Sep ’26n/a
CHF 75.86
0%
4.17%CHF 80.54CHF 71.49n/a10
Aug ’26n/a
CHF 73.73
0%
5.74%CHF 79.96CHF 65.15n/a10
Jul ’26n/a
CHF 71.67
0%
7.80%CHF 79.58CHF 60.85n/a11
Jun ’26n/a
CHF 70.06
0%
10.22%CHF 79.55CHF 56.15n/a12
May ’26n/a
CHF 63.04
0%
10.46%CHF 74.93CHF 52.45n/a14
Apr ’26n/a
CHF 62.65
0%
11.36%CHF 74.03CHF 48.07n/a14
Mar ’26n/a
CHF 61.01
0%
11.35%CHF 72.28CHF 46.93n/a14
Feb ’26n/a
CHF 61.49
0%
11.36%CHF 72.76CHF 47.24n/a14
Jan ’26n/a
CHF 65.83
0%
7.20%CHF 71.40CHF 56.00n/a14
Dec ’25n/a
CHF 67.08
0%
6.76%CHF 71.77CHF 56.29n/a14
Nov ’25n/a
CHF 67.08
0%
6.76%CHF 71.77CHF 56.29n/a14
Oct ’25n/a
CHF 68.43
0%
6.28%CHF 73.11CHF 56.97n/a14
Sep ’25n/a
CHF 65.87
0%
7.02%CHF 72.09CHF 56.18n/a14
Aug ’25n/a
CHF 67.98
0%
8.05%CHF 76.45CHF 57.34n/a14
Jul ’25n/a
CHF 70.25
0%
6.74%CHF 77.57CHF 58.18n/a14
Jun ’25n/a
CHF 70.78
0%
8.16%CHF 78.30CHF 58.73n/a14
CHF 78.95
Fair Value
6.6% undervalued intrinsic discount
10
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/16 04:39
End of Day Share Price 2026/06/08 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cofinimmo SA is covered by 19 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Celine HuynhBarclays
Kai KloseBerenberg
Robert JonesBNP Paribas